Compare FENG & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENG | GRFS |
|---|---|---|
| Founded | 1998 | 1940 |
| Country | China | Spain |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 6.0B |
| IPO Year | 2011 | 2006 |
| Metric | FENG | GRFS |
|---|---|---|
| Price | $2.03 | $9.20 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.15 |
| AVG Volume (30 Days) | 2.5K | ★ 538.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | $106,947,410.00 | ★ $8,821,017,248.00 |
| Revenue This Year | N/A | $5.46 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | $17.68 |
| Revenue Growth | ★ 9.17 | 7.31 |
| 52 Week Low | $1.28 | $6.19 |
| 52 Week High | $3.65 | $11.14 |
| Indicator | FENG | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 57.67 |
| Support Level | $2.01 | $8.81 |
| Resistance Level | $2.08 | $9.22 |
| Average True Range (ATR) | 0.04 | 0.26 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 13.33 | 95.25 |
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.